Changing the Standard of Care: The Case for Combining Pegloticase With Immunomodulatory Agents in Gout
John Botson, MD, provides his perspective on including immunodulatory therapy in combination with pegloticase and encourages clinicians to evolve their standard of care in the treatment of uncontrolled gout.